See All Slides - tctmd.com

Slides

Presentation ACC 2024

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

Presenter: Michael J. Koren

April 06, 2024

Presentation ACC 2024

Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk

Presenter: Ronald Chi Hang Lee

April 06, 2024

Presentation ACC 2024

Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy

Presenter: Yousuf Razvi

April 06, 2024

Presentation ACC 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presenter: C. Michael Gibson

April 06, 2024

Presentation ACC 2024

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Presenter: Javed Butler

April 06, 2024

Presentation ACC 2024

Principal Results from the RELIEVE-HF Trial

Presenter: Gregg W. Stone

April 06, 2024

MicroRNA in Cardiac Transplantation: Biomarkers With Therapeutic Potential

Presentation THT 2024

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Presenter: Palak Shah

March 06, 2024

Presentation THT 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presenter: Dawn E. Bowles

March 06, 2024

Presentation THT 2024

Regulatory Issues Related to the Introduction of New Percutaneous Pumps

Presenter: Navin K. Kapur

March 06, 2024

Presentation THT 2024

Designing a Bionic Heart

Presenter: Ellen Roche

March 06, 2024

Advertisement

Slides

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk

Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Principal Results from the RELIEVE-HF Trial

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Ex Vivo Gene Therapy in Cardiac Allografts

Regulatory Issues Related to the Introduction of New Percutaneous Pumps

Designing a Bionic Heart

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content